DealsEverstone Capital-backed Translumina buys LamedLamed is a market access platform of vascular and cardiovascular products.ByIrien Joseph8 June 2023•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsEuropeHealthcare